Skip to Main Content
TRC_Tech_Canada
Menu
    • Products
      • Hospital Pharmacist's Letter
      • Hospital Pharmacy Technician's Letter
      • Learning Management Portal
      • NatMed Advisor
      • NatMed Pro
      • Pharmacist's Letter
      • Pharmacist's Letter Canada
      • Pharmacy Technician's Letter
      • Pharmacy Technician's Letter Canada
      • Prescriber's Letter
      • RxAdvanced
      • RxSelect

    Subscribe Login
  • Home
  • Letter
    • Current Issue
    • Past Issues
    • Suggest a Topic
  • Browse
    • Subject
    • Charts
    • Natural Medicines Resources
  • New Drugs
  • Help
    • User Support
    • Contact Us
  • Go To CE/CME & Training

Upgrade Your Browser

We no longer support this version of your browser. We recommend that you upgrade to the latest version of Internet Explorer, Firefox, Chrome or Safari to improve your security and experience using this website.

Return to the course you were viewing

Site updates: We have made updates to the logos on our site. This will not impact access to your subscription.
  1. Home
  2. Browse
  3. Psychiatry
  4. Depression
  5. Drugs

Drugs

  • ADHD (49)
  • Anxiety (27)
  • Bipolar Disorder (12)
  • Depression (182)
    • Cardiovascular Disease and Depression (4)
    • Drugs (159)
      • Atypical Antipsychotics (47)
      • Benzodiazepines (31)
      • Bupropion (32)
      • MAOIs (10)
      • SNRIs (67)
      • SSRIs (88)
      • TCAs (33)
      • Typical Antipsychotics (2)
    • Natural Medicines/Supplements (9)
    • Pediatrics (13)
    • Post-Traumatic Stress Disorder (9)
    • Pregnancy (7)
    • Seasonal Affective Disorder (5)
    • Treatment-Resistant Depression (14)
  • Mental Health (25)
  • Resources (108)
  • Schizophrenia (45)
  • Sleep Disorders (66)
  • Substance Use Disorder (152)
151 - 159 of 159 Results
Sort Results:
  • Title: Ascending (A-Z)
  • Date: Newest First
  • Date: Oldest First
Commentary: New Drug: Savella (Milnacipran) March 2009
Guideline: Management of fibromyalgia syndrome in adults (2009) March 2009
Commentary: New Venlafaxine Extended-Release Formulation January 2009
Other: New Venlafaxine Extended-Release Formulation January 2009
Commentary: Time-release Generic Products:
Are They Equivalent To the Brand Product?
May 2008
Commentary: Pristiq (Desvenlafaxine) May 2008
Chart: Authorized Generics Currently Available May 2008
Chart: Drug-induced Long QT Interval November 2007
Commentary: Intravenous Haloperidol (Haldol) November 2007
  • « Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • About Us
  • Our Mission
  • Our Team
  • Testimonials
  • Careers
  • Newsroom
  • Products
  • Pharmacist Solutions
  • Prescriber Solutions
  • Hospital Solutions
  • Retail Solutions
  • Group Practice Solutions
  • Support & Policies
  • Contact Us
  • Access Agreement
  • Privacy Policy

The contents of this website are not intended to be a substitute for professional medical advice, diagnosis, or treatment. See additional information.

© Therapeutic Research Center. All Rights Reserved